Estrella Immunopharma, Inc. (ESLA)
NASDAQ·Healthcare·Biotechnology
$1.06
-2.31%
Mkt Cap $47.08M
No analyst coverage available
We don't have analyst ratings or price target data for Estrella Immunopharma, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.